Search Page

1

Cite

Share

Prozone effect with the VIDAS HIV DUO Ultra assay.

Jnaoui K, Lamarti N, Pâques AT, Goubau P. Jnaoui K, et al. J Clin Virol. 2007 Mar;38(3):273-4. doi: 10.1016/j.jcv.2006.12.001. Epub 2007 Jan 12. J Clin Virol. 2007. PMID: 17223608 No abstract available.

Cite

Share

2

Cite

Share

Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase.

Belge C, Hammond J, Dubois-Deruy E, Manoury B, Hamelet J, Beauloye C, Markl A, Pouleur AC, Bertrand L, Esfahani H, Jnaoui K, Götz KR, Nikolaev VO, Vanderper A, Herijgers P, Lobysheva I, Iaccarino G, Hilfiker-Kleiner D, Tavernier G, Langin D, Dessy C, Balligand JL. Belge C, et al. Among authors: jnaoui k. Circulation. 2014 Jan 28;129(4):451-62. doi: 10.1161/CIRCULATIONAHA.113.004940. Epub 2013 Nov 4. Circulation. 2014. PMID: 24190960

Cite

Share

3

Cite

Share

Upregulation of IL-17, but not of IL-9, in circulating cells of CIS and relapsing MS patients. Impact of corticosteroid therapy on the cytokine network.

Muls N, Jnaoui K, Dang HA, Wauters A, Van Snick J, Sindic CJ, van Pesch V. Muls N, et al. Among authors: jnaoui k. J Neuroimmunol. 2012 Feb 29;243(1-2):73-80. doi: 10.1016/j.jneuroim.2011.12.010. Epub 2012 Jan 14. J Neuroimmunol. 2012. PMID: 22245284

Cite

Share

4

Cite

Share

Transmission network of an HIV type 1 strain with K103N in young Belgian patients from different risk groups.

Ruelle J, Ingels MG, Jnaoui K, Ausselet N, Vincent A, Sasse A, Verhofstede C, Goubau P. Ruelle J, et al. Among authors: jnaoui k. AIDS Res Hum Retroviruses. 2013 Oct;29(10):1306-9. doi: 10.1089/aid.2013.0108. Epub 2013 Jun 26. AIDS Res Hum Retroviruses. 2013. PMID: 23731270

Cite

Share

5

Cite

Share

Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol.

Dessy C, Saliez J, Ghisdal P, Daneau G, Lobysheva II, Frérart F, Belge C, Jnaoui K, Noirhomme P, Feron O, Balligand JL. Dessy C, et al. Among authors: jnaoui k. Circulation. 2005 Aug 23;112(8):1198-205. doi: 10.1161/CIRCULATIONAHA.104.532960. Circulation. 2005. PMID: 16116070

Cite

Share

6

Cite

Share

Comparative evaluation of the VERSANT HIV-1 RNA 1.0 kinetic PCR molecular system (kPCR) for the quantification of HIV-1 plasma viral load.

Ruelle J, Jnaoui K, Lefèvre I, Lamarti N, Goubau P. Ruelle J, et al. Among authors: jnaoui k. J Clin Virol. 2009 Apr;44(4):297-301. doi: 10.1016/j.jcv.2009.01.004. Epub 2009 Feb 18. J Clin Virol. 2009. PMID: 19230753

Cite

Share

7

Cite

Share

Mutations that affect the tropism of DA and GDVII strains of Theiler's virus in vitro influence sialic acid binding and pathogenicity.

Jnaoui K, Minet M, Michiels T. Jnaoui K, et al. J Virol. 2002 Aug;76(16):8138-47. doi: 10.1128/jvi.76.16.8138-8147.2002. J Virol. 2002. PMID: 12134019 Free PMC article.

Cite

Share

8

Cite

Share

Adaptation of Theiler's virus to L929 cells: mutations in the putative receptor binding site on the capsid map to neutralization sites and modulate viral persistence.

Jnaoui K, Michiels T. Jnaoui K, et al. Virology. 1998 May 10;244(2):397-404. doi: 10.1006/viro.1998.9134. Virology. 1998. PMID: 9601508 Free article.

Cite

Share

9

Cite

Share

Analysis of cellular mutants resistant to Theiler's virus infection: differential infection of L929 cells by persistent and neurovirulent strains.

Jnaoui K, Michiels T. Jnaoui K, et al. J Virol. 1999 Sep;73(9):7248-54. doi: 10.1128/JVI.73.9.7248-7254.1999. J Virol. 1999. PMID: 10438812 Free PMC article.

Cite

Share

10

Cite

Share

Genotypic evaluation of etravirine sensitivity of clinical human immunodeficiency virus type 1 (HIV-1) isolates carrying resistance mutations to nevirapine and efavirenz.

Oumar AA, Jnaoui K, Kabamba-Mukadi B, Yombi JC, Vandercam B, Goubau P, Ruelle J. Oumar AA, et al. Among authors: jnaoui k. Acta Clin Belg. 2010 Jul-Aug;65(4):242-4. doi: 10.1179/acb.2010.052. Acta Clin Belg. 2010. PMID: 20954462

Cite

Share